Agilent, SomaLogic team up on Dx technology

Med tech giant Agilent ($A) has signed a deal with SomaLogic to expand access to that company's protein biomarker discovery platform. Neither side is disclosing financial terms, but the agreement will task Agilent with placing SomaLogic's cutting-edge proteomic assay technology in labs around the world. More